MedPath

Topotecan in Treating Children With Refractory Leukemia

Phase 1
Completed
Conditions
Leukemia
Interventions
Registration Number
NCT00002705
Lead Sponsor
National Cancer Institute (NCI)
Brief Summary

Phase I trial to study the effectiveness of topotecan in treating children with refractory leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Detailed Description

OBJECTIVES:

I. Describe the qualitative and quantitative toxic effects, including acute and chronic dose-limiting toxicity, cumulative toxicity, and time to recovery, in pediatric patients with refractory leukemia who are treated with a 30-minute daily infusion of topotecan (TOPO) for up to 12 consecutive days every 3 weeks.

II. Estimate the maximum tolerated dose of TOPO that results in tolerable, predictable, and reversible toxicity.

III. Determine the precautions and supportive therapy that should be used and the clinical and laboratory studies needed to monitor or alter therapy to prevent unacceptable toxicity in these patients.

IV. Observe any antileukemic effects that may occur during this phase I study in which duration of treatment is increased from 7 to 9 and then 12 days and TOPO doses are escalated.

V. Determine the recommended phase II pediatric dose of TOPO. VI. Characterize the pharmacokinetic parameters of TOPO and evaluate changes in these parameters with the first and last doses to determine whether there is drug accumulation.

VII. Correlate, if possible, these pharmacokinetic parameters with clinical response and toxicity.

OUTLINE:

Single-Agent Chemotherapy. Topotecan, TOPO, NSC-609699.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Arm Itopotecan hydrochlorideSingle-Agent Chemotherapy. Topotecan, TOPO, NSC-609699.
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (31)

Emory University Hospital - Atlanta

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Clinique de Pediatrie

πŸ‡¨πŸ‡­

Geneva, Switzerland

Roswell Park Cancer Institute

πŸ‡ΊπŸ‡Έ

Buffalo, New York, United States

Hackensack University Medical Center

πŸ‡ΊπŸ‡Έ

Hackensack, New Jersey, United States

Saint Jude Children's Research Hospital

πŸ‡ΊπŸ‡Έ

Memphis, Tennessee, United States

Montreal Children's Hospital

πŸ‡¨πŸ‡¦

Montreal, Quebec, Canada

Simmons Cancer Center - Dallas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Washington University School of Medicine

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

State University of New York - Upstate Medical University

πŸ‡ΊπŸ‡Έ

Syracuse, New York, United States

Memorial Mission Hospital

πŸ‡ΊπŸ‡Έ

Asheville, North Carolina, United States

Medical City Dallas Hospital

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Hopital Sainte Justine

πŸ‡¨πŸ‡¦

Montreal, Quebec, Canada

Children's Memorial Hospital, Chicago

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

University of Alabama Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Boston Floating Hospital Infants and Children

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Dana-Farber Cancer Institute

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Children's Hospital of Michigan

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

Duke Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Durham, North Carolina, United States

Baylor College of Medicine

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

University of Texas Health Science Center at San Antonio

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

Midwest Children's Cancer Center

πŸ‡ΊπŸ‡Έ

Milwaukee, Wisconsin, United States

University of Arkansas for Medical Sciences

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

University of California San Diego Cancer Center

πŸ‡ΊπŸ‡Έ

La Jolla, California, United States

Shands Hospital and Clinics, University of Florida

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

Lucile Packard Children's Hospital at Stanford

πŸ‡ΊπŸ‡Έ

Palo Alto, California, United States

Via Christi Regional Medical Center

πŸ‡ΊπŸ‡Έ

Wichita, Kansas, United States

MBCCOP - LSU Medical Center

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

Johns Hopkins Oncology Center

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

San Antonio Military Pediatric Cancer and Blood Disorders Center

πŸ‡ΊπŸ‡Έ

Lackland Air Force Base, Texas, United States

University of Puerto Rico School of Medicine Medical Sciences Campus

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

University of Kansas Medical Center

πŸ‡ΊπŸ‡Έ

Kansas City, Kansas, United States

Β© Copyright 2025. All Rights Reserved by MedPath